324 related articles for article (PubMed ID: 16652171)
1. A drug-sensitive genetic network masks fungi from the immune system.
Wheeler RT; Fink GR
PLoS Pathog; 2006 Apr; 2(4):e35. PubMed ID: 16652171
[TBL] [Abstract][Full Text] [Related]
2. Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment.
Wheeler RT; Kombe D; Agarwala SD; Fink GR
PLoS Pathog; 2008 Dec; 4(12):e1000227. PubMed ID: 19057660
[TBL] [Abstract][Full Text] [Related]
3. Caspofungin-induced β(1,3)-glucan exposure in
Wagner AS; Lumsdaine SW; Mangrum MM; Reynolds TB
mBio; 2023 Aug; 14(4):e0007423. PubMed ID: 37377417
[TBL] [Abstract][Full Text] [Related]
4. Nanoscopic cell-wall architecture of an immunogenic ligand in Candida albicans during antifungal drug treatment.
Lin J; Wester MJ; Graus MS; Lidke KA; Neumann AK
Mol Biol Cell; 2016 Mar; 27(6):1002-14. PubMed ID: 26792838
[TBL] [Abstract][Full Text] [Related]
5. Paradoxical growth of Candida albicans in the presence of caspofungin is associated with multiple cell wall rearrangements and decreased virulence.
Rueda C; Cuenca-Estrella M; Zaragoza O
Antimicrob Agents Chemother; 2014; 58(2):1071-83. PubMed ID: 24295973
[TBL] [Abstract][Full Text] [Related]
6. Nature of β-1,3-Glucan-Exposing Features on Candida albicans Cell Wall and Their Modulation.
de Assis LJ; Bain JM; Liddle C; Leaves I; Hacker C; Peres da Silva R; Yuecel R; Bebes A; Stead D; Childers DS; Pradhan A; Mackenzie K; Lagree K; Larcombe DE; Ma Q; Avelar GM; Netea MG; Erwig LP; Mitchell AP; Brown GD; Gow NAR; Brown AJP
mBio; 2022 Dec; 13(6):e0260522. PubMed ID: 36218369
[TBL] [Abstract][Full Text] [Related]
7. Nanoscale effects of caspofungin against two yeast species, Saccharomyces cerevisiae and Candida albicans.
Formosa C; Schiavone M; Martin-Yken H; François JM; Duval RE; Dague E
Antimicrob Agents Chemother; 2013 Aug; 57(8):3498-506. PubMed ID: 23669379
[TBL] [Abstract][Full Text] [Related]
8. Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin.
Stevens DA; Ichinomiya M; Koshi Y; Horiuchi H
Antimicrob Agents Chemother; 2006 Sep; 50(9):3160-1. PubMed ID: 16940118
[TBL] [Abstract][Full Text] [Related]
9. Remasking of Candida albicans β-Glucan in Response to Environmental pH Is Regulated by Quorum Sensing.
Cottier F; Sherrington S; Cockerill S; Del Olmo Toledo V; Kissane S; Tournu H; Orsini L; Palmer GE; Pérez JC; Hall RA
mBio; 2019 Oct; 10(5):. PubMed ID: 31615961
[No Abstract] [Full Text] [Related]
10. Masking of β(1-3)-glucan in the cell wall of Candida albicans from detection by innate immune cells depends on phosphatidylserine.
Davis SE; Hopke A; Minkin SC; Montedonico AE; Wheeler RT; Reynolds TB
Infect Immun; 2014 Oct; 82(10):4405-13. PubMed ID: 25114110
[TBL] [Abstract][Full Text] [Related]
11. Analysis of beta-1,3-glucan assembly in Saccharomyces cerevisiae using a synthetic interaction network and altered sensitivity to caspofungin.
Lesage G; Sdicu AM; Ménard P; Shapiro J; Hussein S; Bussey H
Genetics; 2004 May; 167(1):35-49. PubMed ID: 15166135
[TBL] [Abstract][Full Text] [Related]
12. Emodin Reduces the Activity of (1,3)-
Janeczko M
Pol J Microbiol; 2018; 67(4):463-470. PubMed ID: 30550232
[TBL] [Abstract][Full Text] [Related]
13. Identification of New Antifungal Agents Targeting Chitin Synthesis by a Chemical-Genetic Method.
Li Y; Sun H; Zhu X; Bian C; Wang Y; Si S
Molecules; 2019 Aug; 24(17):. PubMed ID: 31470665
[TBL] [Abstract][Full Text] [Related]
14. Differential adaptation of Candida albicans in vivo modulates immune recognition by dectin-1.
Marakalala MJ; Vautier S; Potrykus J; Walker LA; Shepardson KM; Hopke A; Mora-Montes HM; Kerrigan A; Netea MG; Murray GI; Maccallum DM; Wheeler R; Munro CA; Gow NA; Cramer RA; Brown AJ; Brown GD
PLoS Pathog; 2013; 9(4):e1003315. PubMed ID: 23637604
[TBL] [Abstract][Full Text] [Related]
15. Induction of a high affinity fibronectin receptor in Candida albicans by caspofungin: requirements for beta (1,6) glucans and the developmental regulator Hbr1p.
Pendrak ML; Rodrigues RG; Roberts DD
Med Mycol; 2007 Mar; 45(2):157-68. PubMed ID: 17365652
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia Promotes Immune Evasion by Triggering β-Glucan Masking on the Candida albicans Cell Surface via Mitochondrial and cAMP-Protein Kinase A Signaling.
Pradhan A; Avelar GM; Bain JM; Childers DS; Larcombe DE; Netea MG; Shekhova E; Munro CA; Brown GD; Erwig LP; Gow NAR; Brown AJP
mBio; 2018 Nov; 9(6):. PubMed ID: 30401773
[TBL] [Abstract][Full Text] [Related]
17. Macrophage reporter cell assay for screening immunopharmacological activity of cell wall-active antifungals.
Lewis RE; Liao G; Young K; Douglas C; Kontoyiannis DP
Antimicrob Agents Chemother; 2014; 58(3):1738-43. PubMed ID: 24395226
[TBL] [Abstract][Full Text] [Related]
18. Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates.
Park S; Kelly R; Kahn JN; Robles J; Hsu MJ; Register E; Li W; Vyas V; Fan H; Abruzzo G; Flattery A; Gill C; Chrebet G; Parent SA; Kurtz M; Teppler H; Douglas CM; Perlin DS
Antimicrob Agents Chemother; 2005 Aug; 49(8):3264-73. PubMed ID: 16048935
[TBL] [Abstract][Full Text] [Related]
19. Cell wall integrity is linked to mitochondria and phospholipid homeostasis in Candida albicans through the activity of the post-transcriptional regulator Ccr4-Pop2.
Dagley MJ; Gentle IE; Beilharz TH; Pettolino FA; Djordjevic JT; Lo TL; Uwamahoro N; Rupasinghe T; Tull DL; McConville M; Beaurepaire C; Nantel A; Lithgow T; Mitchell AP; Traven A
Mol Microbiol; 2011 Feb; 79(4):968-89. PubMed ID: 21299651
[TBL] [Abstract][Full Text] [Related]
20. Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal beta-glucan exposure.
Hohl TM; Feldmesser M; Perlin DS; Pamer EG
J Infect Dis; 2008 Jul; 198(2):176-85. PubMed ID: 18500928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
